THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — A widely used medicine for autoimmune diseases may lower people’s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis. “OurContinue Reading